Thank you to our speakers, sponsors, and delegates who joined us in Boston for the summit!

Thank You for Attending the 9th Annual 3D Tissue Models Summit 2024!

The FDA Modernization Act 2.0 has triggered a new mindset for pharma, with Roche launching the Institute of Human Biology to create better models, and MSD collaborating with Inventia to bioprint 3D in vitro models to screen for neurodegenerative therapeutic candidates.

It has never been a more exciting time to bet on 3D tissue models as the future of drug development, as more and more complex in vitro models undergo validation. However, the big question of “ Are they going to be economically viable as a drug development tool, what is the return on investment for us, and how to do it at scale?” persists at the forefront of biopharma leaders’ thoughts.

Making its timely return to Boston this May, the 9th 3D Tissue Models Summit will enable you and your team to uncover best practices of complex in vitro model use across drug discovery and development through 23+ practical case studies. Join us to learn from and meet the ‘front-line’ experts optimizing and leveraging advanced 3D tissue models to confidently empower your own drug development workflows in a time-efficient and cost-effective way.

What we saw in 2024:

3D tissue - icon 2

Uncover best practice to interrogate renal pathophysiology using 3D ex vivo cell culture with Pfizer to supercharge the target validation process 

3D tissue - icon 4

Discover methodologies to validate the pathobiology of lung organoid and organ-on-a-chip models with Boehringer Ingelheim to better support candidate efficacy studies

3D tissue - icon 5

Interrogate the big question of model complexity with Merck to uncover how the study question can affect model design and use 

3D tissue - icon 3

Explore optimized strategies to maintain model replicability within intestinal organoids with Regeneron to ensure efficient scaling up in drug discovery endeavours 

3D tissue - icon 1

Understand techniques to employ brain organoids across drug discovery with BrainStorm Therapeutics to identify clinical candidates for neurological disorders

Expert Speakers Included:

Colin Speaker

Colin Choi

Associate Scientific Director


Jason Ekert-Speaker-9th 3D Tissue Models Summit 2024

Jason Ekert

Head of Discovery Translational Technology


Muriel Speaker

Muriel Lize

Associate Director in vitro respiratory research

Boehringer Ingelheim

Sai Speaker

Sai Pavan Grandhi

Principal Scientist, Complex In Vitro Models

GlaxoSmithKline Plc

Simone Speaker

Simone Romoli

Principal Scientist


Companies that Attended:

Previous attending company
Chugai_Pharmaceutical-Attendees-9th 3D Tissue Models Summit
Eisai-Attendees-9th 3D Tissue Models Summit
FDA-Attendees-9th 3D Tissue Models Summit
Incyte-Attendees-9th 3D Tissue Models Summit
Merck-Attendees-9th 3D Tissue Models Summit

Our 2024 Partners:

Corning 2024 Partner
molecular devices
bennubio 2024 Partner